Successfully Driving Drug Discovery and Development Using the Virtual Pharmaceutical Model
Contributor:
Helen Winsor
Posted: 10/08/2010 12:00:00 AM EDT | 0
Posted: 10/08/2010 12:00:00 AM EDT | 0
|
An estimated 25 per cent of R&D budgets are now being spent on externalisation, it is crucial to develop strategic and effective business models and determine how best to outsource the different processes of drug discovery.
In this interview Sophie Hallakou-Bozec, Research Director and Cofounder of Poxel, speaks to Hel...
-
Vaccine Manufacturing: Preparing for a Pandemic -
Hospitals Need to See Benefit in ICT for Mapping Capacity -
Regulatory Strategy in Japan: How to Maximise your Chances of Success -
Medical Devices: Directives and Standards -
Ironing Out Inconsistencies with GCP Auditing -
Biobanking Grows in Scale -
Potential and Capabilities of the Clinical Research Sector -
Software Design for Medical Devices -
Multiparticulate Drug Delivery Systems -
Bringing Innovation to Clinical Design
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest
-
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
March 28, 2012
Register Now -
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys
January 13, 2012
Register Now -
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!